PTGS2 and colorectal neoplasm: Furthermore, low 15-PGDH levels are associated with resistance to COX-2 selective inhibitor Celecoxib chemopreventive effects in colorectal tumors development, reinforcing the impact of loss of 15-PGDH expression in colorectal carcinogenesis [13].